
New recommendations on finasteride and Ixchiq vaccine

Measures minimise risk of suicidal thoughts

EU regulators agree workplan to optimise use of data and AI

Vaccine must not be used in people 65 years and above

Public consultation open until end September 2025

Seizing opportunities in a changing medicines landscape
Find medicine
What's new
FAQs
Latest news

Review of medicines containing finasteride and dutasteride concluded
Suicidal thoughts confirmed as side effect of finasteride tablets; no direct link found for dutasteride

EU regulators agree workplan to optimise use of data and artificial intelligence (AI)
Vaccine must not be used in people 65 years and above while review is underway
The European Medicines Agency's (EMA) office is closed from 18:00 on 8 May 2025 to 08:30 on 12 May 2025
Consultation of the Board constitutes first step of renewal process